OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 151: Line 151:
|  
|  
|--
|--
| <font color=red>2/17/2012</font>  
| <font color=red>2/1/2013</font>  
|  
|  
Lisa Coussens
|
| Breast Cancer:Inflammation and Breast Cancer: Targeting Macrophages to Enhance Chemotherapy
|  
|  
|
|
|--
|--
|2/24/2012
|2/8/2013
|George Thomas
|
|Re-thinking Targeted Therapies for Kidney Cancer
|
|  
|  
|  
|  
|--
|--
| <font color=red>3/2/2012</font>  
| <font color=red>2/15/2013</font>  
|Juha Rantala
|
Koei Chin 
|Breast Cancer (Rantala): Targeted RNAi screens in breast cancer cells using cell spot microarrays.
 
Breast Cancer (Chin): Omics Analysis in Breast Cancer: Genome to Protein
|
|
|
|
|--
|--
|3/9/2012
|2/22/2013
|Daniel Marks
|
|Brain Mechanisms in Cancer Cachexia
|  
|  
|
|
|--
|--
| <font color=red>3/16/2012</font>  
| <font color=red>3/1/2013</font>  
|Xiangshu Xiao
|
|Breast Cancer: Small Molecules Targeting CREB for Breast Cancer Therapy
|
|  
|  
|
|
|--
|--
|3/23/2012
|3/8/2013
|Canceled for the 2012 BioMedicine in 4D Conference
|  
|[http://www.ohsu.edu/xd/education/schools/school-of-medicine/departments/basic-science-departments/biomedical-engineering/spatial-systems-biomedicine/conference.cfm]
|  
|  
|
|
|--
|--
| 3/30/2012
| 3/15/2013
|NO MEETING
|
| Spring Break
|  
|  
|  
|
|
|--
|--
|<font color=red>4/6/2012</font>
|<font color=red>3/22/2013</font>
| Allen Ebens, PhD
|
| The role of PI3 and PIM kinases in multiple myeloma
|  
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|--
|--
|4/13/2012
|3/29/2013
|Jen Vomaske
|CANCEL - SPRING BREAK
|CXCR7-mediated Endothelial Dysfunction: Implications for Tumor Vascular Normalization
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|
|--
|--
| <font color=red>4/20/2012</font>  
| <font color=red>4/5/2013</font>  
| Zhi Hu
|  
 
|  
Wassana Yantasee
|
 
|
| Part I. Optimization of therapeutic siRNA against HER2 (Hu)
 
Part II. Nanoparticle platform for siRNA delivery and HER2 silencing (Yantasee)
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|--
|4/27/2012
|4/12/2012
|Lucia Carbone
|  
|Mechanisms of chromosomal rearrangement in evolution and cancer
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|
|--
|--
| <font color=red>5/4/2012</font>  
| <font color=red>4/19/2013</font>  
|Joe Gray
|
 
|
Paul Spellman
|
|Breast Cancer: Prospects for interrogating the signaling nanostructure of breast cancer
 
Breast Cancer:Genomic Analysis of Breast Cancers. Beyond TCGA
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|--
|5/11/2012
|4/26/2013
|Wong Lab (Nick Smith, Emily Bubbers)
|
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|
|
|--
|--
| <font color=red>5/18/2012</font>  
| <font color=red>5/3/2013</font>  
| John Muschler
|  
 
|
Sunjong Kwon
|
 
|Breast Cancer
Sunjong Kwon: Quantitative Imaging of individual mRNAs and co-staining of protein in breast cancer cells
|<font color=green> ***Note the location change ***
|MAC HALL 2201
|--
|--
| <font color=red>5/25/2012</font>
| 5/10/2013
|Brainstorming - Breast Cancer Focus
|
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|  
|--
|--
|6/8/2012
|<font color=red>5/17/2013</font>
|Kinrin Yamanaka (Dr. Stephen Lloyd lab)
|
|Molecular Targeting of Translesion Synthesis DNA Polymerases for Novel Combination Chemotherapy
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|--
|--
|6/15/2012
|5/24/2013
|Liskay Lab
|
|Inhibiting occult clonal expansion of mutant cells as a mechanism of chemoprevention
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|
|--
|--
|6/22/2012
|<font color=red>5/31/2013</font>
|Neil Osheroff
|
|Vanderbilt
|
|<font color=green> ***Note the location change ***
|
|MAC HALL 2201
|
|--
|6/7/2013
|
|
|
|
|--
|<font color=red>6/14/2013</font>
|
|
|
|

Revision as of 10:33, 31 August 2012

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Knight Cancer Biology Research Group Meetings

Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:

  • Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
  • Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:

  • Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
  • Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.

Knight Research Group Activities

Want to join us? All are invited!

To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
follow the instructions for subscribing
  • We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
Fridays 9:15-10:15 AM - see schedule below
Breakfast provided by the Knight!
  • Organizer: Rosie Sears, email searsrATohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab, MMG

Hoatlin Lab, BMB

Thayer Lab, BMB

Lloyd Lab, CROET

McCullough Lab, CROET

Wong Lab, Dermatology, CDB

Zundel Lab, Radiation Medicine, Cancer Biology

Spindel Lab, Primate Center, NGP, Cancer Biology

  • Add your lab here

Schedule

*Red indicates Translational Cancer Research Group Meetings

Date Presenters Topic Links & Comments Location
9/21/2012
9/28/2012 Hematologic Malignancies -
10/5/2012
10/12/2012 Hematologic Malignancies -
10/19/2012
10/26/2012 Hematologic Malignancies -
11/2/2012
11/9/2012 Hematologic Malignancies -
11/16/2012
11/30/2012 Hematologic Malignancies -
12/7/2012
12/14/2012 Hematologic Malignancies - Brain storming
12/21/2012
1/4/2013
1/11/2013
1/18/2013
1/25/2013
2/1/2013
2/8/2013
2/15/2013
2/22/2013
3/1/2013
3/8/2013
3/15/2013
3/22/2013
3/29/2013 CANCEL - SPRING BREAK
4/5/2013
4/12/2012
4/19/2013
4/26/2013
5/3/2013
5/10/2013
5/17/2013
5/24/2013
5/31/2013
6/7/2013
6/14/2013
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Research_Group_Meetings&oldid=621812"